 |
PDBsum entry 3kaf
|
|
|
|
 |
Contents |
 |
|
|
|
|
|
|
|
|
|
|
|
* Residue conservation analysis
|
|
|
|
 |
|
|
 |
 |
 |
 |
Enzyme class:
|
 |
E.C.5.2.1.8
- peptidylprolyl isomerase.
|
|
 |
 |
 |
 |
 |
Reaction:
|
 |
[protein]-peptidylproline (omega=180) = [protein]-peptidylproline (omega=0)
|
 |
 |
 |
 |
 |
Peptidylproline (omega=180)
|
=
|
peptidylproline (omega=0)
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Molecule diagrams generated from .mol files obtained from the
KEGG ftp site
|
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
|
|
| |
|
|
| |
|
|
Bioorg Med Chem Lett
20:586-590
(2010)
|
|
PubMed id:
|
|
|
|
|
| |
|
Structure-guided design of alpha-amino acid-derived Pin1 inhibitors.
|
|
A.J.Potter,
S.Ray,
L.Gueritz,
C.L.Nunns,
C.J.Bryant,
S.F.Scrace,
N.Matassova,
L.Baker,
P.Dokurno,
D.A.Robinson,
A.E.Surgenor,
B.Davis,
J.B.Murray,
C.M.Richardson,
J.D.Moore.
|
|
|
|
| |
ABSTRACT
|
|
|
| |
|
The peptidyl prolyl cis/trans isomerase Pin1 is a promising molecular target for
anti-cancer therapeutics. Here we report the structure-guided evolution of an
indole 2-carboxylic acid fragment hit into a series of
alpha-benzimidazolyl-substituted amino acids. Examples inhibited Pin1 activity
with IC(50) <100nM, but were inactive on cells. Replacement of the
benzimidazole ring with a naphthyl group resulted in a 10-50-fold loss in ligand
potency, but these examples downregulated biomarkers of Pin1 activity and
blocked proliferation of PC3 cells.
|
|
|
|
|
|
|
 |
 |
|
 |
 |
 |
 |
 |
 |
 |
 |
 |
|
Literature references that cite this PDB file's key reference
|
|
 |
| |
PubMed id
|
 |
Reference
|
 |
|
|
|
 |
L.Zhu,
J.Jin,
C.Liu,
C.Zhang,
Y.Sun,
Y.Guo,
D.Fu,
X.Chen,
and
B.Xu
(2011).
Synthesis and biological evaluation of novel quinazoline-derived human Pin1 inhibitors.
|
| |
Bioorg Med Chem,
19,
2797-2807.
|
 |
|
 |
 |
|
The most recent references are shown first.
Citation data come partly from CiteXplore and partly
from an automated harvesting procedure. Note that this is likely to be
only a partial list as not all journals are covered by
either method. However, we are continually building up the citation data
so more and more references will be included with time.
|
');
}
}
 |